Vitenskapelig oversiktsartikkel/review

• Minnen, L. M. van der; Grooten, I.J.; Dean, C. et al. (2025). The impact and management of hyperemesis gravidarum: Current and future perspectives. (ekstern lenke)
• Fejzo, Marlena Schoenberg; Trovik, Jone; Grooten, Iris J. et al. (2019). Nausea and vomiting of pregnancy and hyperemesis gravidarum. (ekstern lenke)
• Salvesen, Helga Birgitte; Haldorsen, Ingfrid S.; Trovik, Jone (2012). Markers for individualised therapy in endometrial carcinoma. (ekstern lenke)

Vitenskapelig artikkel

• Sharami, Alexander Nima; Feiring, Mari Heide; Eide, Ellen Nydal et al. (2025). Long-term patient-reported outcome for surgical management of pelvic organ prolapse: A retrospective cohort study. (ekstern lenke)
• Lura, Njål; Wagner-Larsen, Kari Strøno; Ryste, Stian Torkildson et al. (2025). Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer. (ekstern lenke)
• Berg, Hege Fredriksen; Trovik, Jone; Hjelmeland, Marta Espevold et al. (2025). Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining. (ekstern lenke)
• Meijs-Hermanns, Puk; Werner, Henrica Maria Johanna; Kooreman, Loes et al. (2025). Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma. (ekstern lenke)
• Hjelmeland, Marta Espevold; Lien, Hilde Eide; Berg, Hege Fredriksen et al. (2024). Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer. (ekstern lenke)
• Erdal, Hilde; Holst, Lone; Heitmann, Kristine et al. (2024). Guidelines for Treatment of Hyperemesis Gravidarum and Implementation in Clinical Practice in Norway: A Descriptive Study. (ekstern lenke)
• Berg, Madeleine Charlotte van der; Berg, Hege Fredriksen; Stokowy, Tomasz et al. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (ekstern lenke)
• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (ekstern lenke)
• Berg, Hege Fredriksen; Engerud, Hilde Renate; Myrvold, Madeleine et al. (2022). Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. (ekstern lenke)
• Wagner-Larsen, Kari Strøno; Lura, Njål Gjærde; Salvesen, Øyvind et al. (2022). Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer. (ekstern lenke)
• Lura, Njål Gjærde; Wagner-Larsen, Kari Strøno; Forsse, David Erik et al. (2022). What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?. (ekstern lenke)
• Dybvik, Julie Andrea; Fasmer, Kristine Eldevik; Ytre-Hauge, Sigmund et al. (2022). MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. (ekstern lenke)
• Erdal, Hilde; Holst, Lone; Heitmann, Kristine et al. (2022). Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019. (ekstern lenke)
• Fasmer, Kristine Eldevik; Gulati, Ankush; Dybvik, Julie Andrea et al. (2022). Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?. (ekstern lenke)
• Lindemann, Kristina Yvonne Kathe; Smogeli, Aud Elisabeth Farstad; Småstuen, Milada Cvancarova et al. (2021). Salvage radiation for pelvic relapse after surgically treated endometrial cancer. (ekstern lenke)
• Fonnes, Tina; Telle, Ingrid Ovidia Moe; Forsse, David Erik et al. (2021). Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers. (ekstern lenke)
• Forsse, David Erik; Barbero, Mark Lewis B Barbero; Werner, Henrica Maria Johanna et al. (2021). Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study. (ekstern lenke)
• Halle, Mari Kyllesø; Sødal, Marte; Forsse, David Erik et al. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (ekstern lenke)
• Vrede, S.W.; Weelden, Willem Jan van; Visser, Nicole C.M. et al. (2021). Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. (ekstern lenke)
• Dean, Caitlin R; Bierma, Hyke; Clarke, Ria et al. (2021). A patient-clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarum. (ekstern lenke)
• Pedersen, Judith Krossøy; Sira, Cecilie; Trovik, Jone (2021). Handheld transabdominal ultrasound, after limited training, may confirm first trimester viable intrauterine pregnancy: a prospective cohort study. (ekstern lenke)
• Jacob, Havjin; Dybvik, Julie Andrea; Ytre-Hauge, Sigmund et al. (2021). An mri-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer. (ekstern lenke)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (ekstern lenke)
• Engerud, Hilde Renate; Berg, Hege Fredriksen; Myrvold, Madeleine et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (ekstern lenke)
• Berg, Hege Fredriksen; Ju, Zhenlin; Myrvold, Madeleine et al. (2020). Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. (ekstern lenke)
• Fasmer, Kristine Eldevik; Gulati, Ankush; Dybvik, Julie Andrea et al. (2020). Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. (ekstern lenke)
• Reijnen, Casper; Gogou, Evangelia; Visser, Nicole C.M. et al. (2020). Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. (ekstern lenke)
• Ytre-Hauge, Sigmund; Salvesen, Øyvind; Krakstad, Camilla et al. (2020). Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. (ekstern lenke)
• Virdee, Navneet Kaur; Ringdal, Emilie Kallåk; Thornhill, Heidi Frances et al. (2020). Gynekologiske fistler etter kirurgi og strålebehandling. (ekstern lenke)
• Forsse, David Erik; Berg, Hege Fredriksen; Bozickovic, Olivera et al. (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. (ekstern lenke)
• Fasmer, Kristine Eldevik; Hodneland, Erlend; Dybvik, Julie Andrea et al. (2020). Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. (ekstern lenke)
• Kleppe, Andreas; Albregtsen, Fritz; Trovik, Jone et al. (2020). Prognostic value of the diversity of nuclear chromatin compartments in gynaecological carcinomas. (ekstern lenke)
• Meinich, Tale Jeanette; Trovik, Jone (2020). Early maternal weight gain as a risk factor for SGA in pregnancies with hyperemesis gravidarum: A 15-year hospital cohort study. (ekstern lenke)
• Helleland, Liva; Bergesen, Lena Flekke; Rinnan, Karen Jakobsen et al. (2019). Endometrial ablation; Less is more? Historical cohort study comparing long-term outcomes from two time periods and two treatment modalities for 854 women. (ekstern lenke)
• Holst, Frederik; Werner, Henrica Maria Johanna; Mjøs, Siv et al. (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. (ekstern lenke)
• Forsse, David Erik; Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik et al. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. (ekstern lenke)
• Reijnen, Casper; Weelden, Willem Jan van; Arts, Martijn S.J.P. et al. (2019). Poor outcome in hypoxic endometrial carcinoma is related to vascular density. (ekstern lenke)
• Changole, Josephine; Thorsen, Viva Combs; Trovik, Jone et al. (2019). Coping with a disruptive life caused by obstetric fistula: Perspectives from Malawian women. (ekstern lenke)
• Strand, Elin; Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik et al. (2019). Blood metabolites associate with prognosis in endometrial cancer. (ekstern lenke)
• Visser, Nicole C.M.; Putten, Louis J.M. van der; Egerschot, Alex van et al. (2019). Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study. (ekstern lenke)
• Zhao, Y.; Yang, Y.; Trovik, Jone et al. (2019). Novel PCDH10-Wnt-MALAT1 regulatory axis in endometrioid endometrial adenocarcinoma. (ekstern lenke)
• Engerud, Hilde Renate; Hope, Kirsten Øvergaard; Berg, Hege Fredriksen et al. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. (ekstern lenke)
• Børseth, Katrine Trovik Flaatten; Acharya, Ganesh; Kiserud, Torvid et al. (2019). Incidence of gynecological fistula and its surgical treatment: A national registry-based study. (ekstern lenke)
• Versluis, Mac; Plat, Annechien; Bruyn, Marco de et al. (2018). L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. (ekstern lenke)
• Kusonmano, Kanthida; Halle, Mari Kyllesø; Wik, Elisabeth et al. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. (ekstern lenke)
• Bollineni, Vikram Rao; Ytre-Hauge, Sigmund; Gulati, Ankush et al. (2018). The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients. (ekstern lenke)
• Nielsen, Birgitte; Kleppe, Andreas; Hveem, Tarjei Sveinsgjerd et al. (2018). Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers. (ekstern lenke)
• Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik; Konings, Gonda F et al. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. (ekstern lenke)
• Putten, Louis J.M. Van Der; Visser, Nicole C.M.; Vijver, Koen Van De et al. (2018). Added value of estrogen receptor, progesterone receptor, and L1 cell adhesion molecule expression to histology-based endometrial carcinoma recurrence prediction models: An ENITEC Collaboration study. (ekstern lenke)
• Kleppe, Andreas; Albregtsen, Fritz; Vlatkovic, Ljiljana et al. (2018). Chromatin organisation and cancer prognosis: a pan-cancer study. (ekstern lenke)
• Bischof, Katharina; Knappskog, Stian; Stefansson, Ingunn et al. (2018). High expression of the p53 isoform ? is associated with reduced progression-free survival in uterine serous carcinoma. (ekstern lenke)
• Painter, Jodie N.; O'Mara, Tracy A.; Morris, Andrew P. et al. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. (ekstern lenke)
• Fasmer, Kristine Eldevik; Bjørnerud, Atle; Ytre-Hauge, Sigmund et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (ekstern lenke)
• O'Mara, Tracy A.; Glubb, Dylan M.; Amant, Frédéric et al. (2018). Identification of nine new susceptibility loci for endometrial cancer. (ekstern lenke)
• Fonnes, Tina; Trovik, Jone; Edqvist, Per-Henrik D. et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (ekstern lenke)
• Ytre-Hauge, Sigmund; Dybvik, Julie Andrea; Lundervold, Arvid et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (ekstern lenke)
• Halle, Mari Kyllesø; Ojesina, Akinyemi I; Engerud, Hilde Renate et al. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (ekstern lenke)
• Mauland, Karen Klepsland; Ju, Zhenlin; Tangen, Ingvild Løberg et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (ekstern lenke)
• Cuppens, Tine; Annibali, Daniela; Coosemans, An et al. (2017). Potential targets' analysis reveals dual PI3K/mTOR pathway inhibition as a promising therapeutic strategy for uterine leiomyosarcomas - An ENITEC group initiative. (ekstern lenke)
• Halle, Mari Kyllesø; Tangen, Ingvild Løberg; Berg, Hege Fredriksen et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (ekstern lenke)
• Fonnes, Tina; Berg, Hege Fredriksen; Onyango, Therese Bredholt et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (ekstern lenke)
• Eritja, Nuria; Jove, Mariona; Fasmer, Kristine Eldevik et al. (2017). Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. (ekstern lenke)
• Berg, Anna; Gulati, Ankush; Ytre-Hauge, Sigmund et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (ekstern lenke)
• Visser, Nicole C.M.; Werner, Henrica Maria Johanna; Krakstad, Camilla et al. (2017). Type of vascular invasion in association with progress of endometrial cancer. (ekstern lenke)
• Yang, Xueying; Wang, Chi Chiu; Lee, Wayne Yuk Wai et al. (2017). Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U. (ekstern lenke)
• Tangen, Ingvild Løberg; Kopperud, Reidun Kristin; Visser, Nicole C.M. et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (ekstern lenke)
• Ytre-Hauge, Sigmund; Esmaeili, Morteza; Sjøbakk, Torill Eidhammer et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (ekstern lenke)
• Tangen, Ingvild Løberg; Venereis, Jennifer Taylor; Halle, Mari Kyllesø et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (ekstern lenke)
• Mauland, Karen Klepsland; Eng, Øyvin Andre Solberg; Ytre-Hauge, Sigmund et al. (2017). High visceral fat percentage is associated with poor outcome in endometrial cancer. (ekstern lenke)
• Njølstad, Tormund Salvesen; Werner, Henrica Maria Johanna; Marcickiewicz, Janusz et al. (2017). Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study. (ekstern lenke)
• Mjøs, Siv; Werner, Henrica Maria Johanna; Birkeland, Even et al. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. (ekstern lenke)
• Thompson, Deborah J.; O'Mara, Tracy A.; Glubb, Dylan M. et al. (2016). CYP19A1 fine-mapping and Mendelian randomization: Estradiol is causal for endometrial cancer. (ekstern lenke)
• Painter, Jodie N.; O'Mara, Tracy A.; Marquart, Louise et al. (2016). Genetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer. (ekstern lenke)
• Gibson, William J.; Høivik, Erling Andre; Halle, Mari Kyllesø et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (ekstern lenke)
• Tangen, Ingvild Løberg; Onyango, Therese Bredholt; Kopperud, Reidun Kristin et al. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. (ekstern lenke)
• Hveem, Tarjei Sveinsgjerd; Njølstad, Tormund Salvesen; Nielsen, Birgitte et al. (2016). Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer. (ekstern lenke)
• Mauland, Karen Klepsland; Wik, Elisabeth; Høivik, Erling Andre et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (ekstern lenke)
• Yang, Ji-Yeon; Werner, Henrica Maria Johanna; Li, Jie et al. (2016). Integrative protein-based prognostic model for early-stage endometrioid endometrial cancer. (ekstern lenke)
• Cheng, Timothy H.T.; Thompson, Deborah J.; O'Mara, Tracy A. et al. (2016). Five endometrial cancer risk loci identified through genome-wide association analysis. (ekstern lenke)
• Putten, Louis J.M. Van Der; Visser, Nicole C.M.; Vijver, Koen Van de et al. (2016). L1CAM expression in endometrial carcinomas: An ENITEC collaboration study. (ekstern lenke)
• Trovik, Jone; Vikanes, Åse Vigdis (2016). Hyperemesis Gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering. (ekstern lenke)
• Trovik, Jone; Thornhill, Heidi Frances; Kiserud, Torvid (2016). Incidence of obstetric fistula in Norway: A population-based prospective cohort study. (ekstern lenke)
• Holst, Frederik; Høivik, Erling Andre; Gibson, William J. et al. (2016). Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth. (ekstern lenke)
• Berg, Anna; Fasmer, Kristine Eldevik; Mauland, Karen Klepsland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (ekstern lenke)
• Painter, Jodie N.; O'Mara, Tracy A.; Batra, Jyotsna et al. (2015). Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. (ekstern lenke)
• Ytre-Hauge, Sigmund; Husby, Jenny Hild Aase; Magnussen, Inger Johanne et al. (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. (ekstern lenke)
• Carvajal-Carmona, Luis G.; O'Mara, Tracy A.; Painter, Jodie N. et al. (2015). Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. (ekstern lenke)
• Birkeland, Elisabeth Sofie; Stokke, Guro; Tangvik, Randi Julie et al. (2015). Norwegian PUQE (pregnancy-unique quantification of emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: A prospective cohort validation study. (ekstern lenke)
• Cheng, Timothy H.T.; Thompson, Deborah; Painter, Jodie et al. (2015). Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. (ekstern lenke)
• Stefansson, Ingunn; Ræder, Maria B; Wik, Elisabeth et al. (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. (ekstern lenke)
• Berg, Anna; Høivik, Erling Andre; Mjøs, Siv et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (ekstern lenke)
• Bredholt, Geir; Mannelqvist, Monica; Stefansson, Ingunn et al. (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. (ekstern lenke)
• Krakstad, Camilla; Tangen, Ingvild Løberg; Høivik, Erling Andre et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (ekstern lenke)
• O'Mara, Tracy A.; Glubb, Dylan M.; Painter, Jodie N. et al. (2015). Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. (ekstern lenke)
• Stokke, Guro; Gjelsvik, Bente Leirvåg; Flaatten, Katrine Trovik et al. (2015). Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: A 10-year retrospective cohort study. (ekstern lenke)
• Husby, Jenny Hild Aase; Salvesen, Øyvind; Magnussen, Inger Johanne et al. (2015). Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. (ekstern lenke)
• Njølstad, Tormund Salvesen; Trovik, Jone; Hveem, Tarjei Sveinsgjerd et al. (2015). DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer. (ekstern lenke)
• Husby, Jenny Hild Aase; Reitan, Bernt Christian; Biermann, Martin et al. (2015). Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. (ekstern lenke)
• Mackay, Helen; Eisenhauer, Elizabeth A.; Kamel-Reid, Suzanne et al. (2014). Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. (ekstern lenke)
• Haldorsen, Ingfrid S.; Stefansson, Ingunn; Grüner, Renate et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (ekstern lenke)
• Carvajal-Carmona, Luis G.; O'Mara, Tracy A; Painter, Jodie N et al. (2014). Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. (ekstern lenke)
• Høivik, Erling Andre; Kusonmano, Kanthida; Halle, Mari Kyllesø et al. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. (ekstern lenke)
• Werner, Henrica Maria Johanna; Trovik, Jone; Halle, Mari Kyllesø et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (ekstern lenke)
• Tangen, Ingvild Løberg; Werner, Henrica Maria Johanna; Berg, Anna et al. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. (ekstern lenke)
• Zhao, Yu; Yang, Yihua; Trovik, Jone et al. (2014). A novel Wnt regulatory axis in endometrioid endometrial cancer. (ekstern lenke)
• Alonso-Alconada, Lorena; Muinelo-Romay, Laura; Madissoo, Kadri et al. (2014). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. (ekstern lenke)
• Wik, Elisabeth; Trovik, Jone; Kusonmano, Kanthida et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (ekstern lenke)
• Trovik, Jone; Salvesen, Helga; Cuppens, Tine et al. (2014). Growth differentiation factor-15 as biomarker in uterine sarcomas. (ekstern lenke)
• Engerud, Hilde Renate Haugen; Tangen, Ingvild Løberg; Berg, Ansgar et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (ekstern lenke)
• Tangen, Ingvild Løberg; Krakstad, Camilla; Halle, Mari Kyllesø et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (ekstern lenke)
• Njølstad, Tormund Salvesen; Engerud, Hilde Renate H; Werner, Henrica Maria Johanna et al. (2013). Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. (ekstern lenke)
• Werner, Henrica Maria Johanna; Berg, Anna; Wik, Elisabeth et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (ekstern lenke)
• Werner, Henrica Maria Johanna; Trovik, Jone; Marcickiewicz, Janusz et al. (2013). A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis. (ekstern lenke)
• Haldorsen, Ingfrid S.; Grüner, Renate; Husby, Jenny Hild Aase et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (ekstern lenke)
• Wik, Elisabeth; Birkeland, Even; Trovik, Jone et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (ekstern lenke)
• Wik, Elisabeth; Ræder, Maria B; Krakstad, Camilla et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Werner, Henrica Maria Johanna et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (ekstern lenke)
• Ræder, Maria B; Birkeland, Even; Trovik, Jone et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (ekstern lenke)
• Delahanty, Ryan J.; Xiang, Yong-Bing; Spurdle, Amanda et al. (2013). Polymorphisms in inflammation pathway genes and endometrial cancer risk. (ekstern lenke)
• Krakstad, Camilla; Trovik, Jone; Wik, Elisabeth et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (ekstern lenke)
• Krakstad, Camilla; Birkeland, Even; Seidel, Danila et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. (ekstern lenke)
• Werner, Henrica Maria Johanna; Trovik, Jone; Marcickiewicz, Janusz et al. (2012). Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. (ekstern lenke)
• Birkeland, Even; Wik, Elisabeth; Mjøs, Siv et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (ekstern lenke)
• Knappskog, Stian; Gansmo, Liv Beathe; Romundstad, Pål Richard et al. (2012). MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk. (ekstern lenke)
• Haldorsen, Ingfrid S.; Husby, Jenny Hild Aase; Werner, Henrica Maria Johanna et al. (2012). Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists. (ekstern lenke)
• Knappskog, Stian; Trovik, Jone; Marcickiewicz, Janusz et al. (2012). SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer. (ekstern lenke)
• Long, Jirong; Zheng, Wei; Xiang, Yong-Bing et al. (2012). Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. (ekstern lenke)
• Trovik, Jone; Mauland, Karen Klepsland; Werner, Henrica Maria Johanna et al. (2012). Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective. (ekstern lenke)
• Haldorsen, Ingfrid S.; Berg, Anna; Werner, Henrica Maria Johanna et al. (2012). Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. (ekstern lenke)
• Spurdle, Amanda B; Ahmed, Shahana; Ferguson, Kaltin et al. (2011). Genome-wide association study identifies a common variant associated with risk of endometrial cancer. (ekstern lenke)
• Staff, Anne Cathrine; Trovik, Jone; Eriksson, Ane Gerda Zahl et al. (2011). Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer. (ekstern lenke)
• Mauland, Karen Klepsland; Trovik, Jone; Wik, Elisabeth et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (ekstern lenke)
• Vandenput, Ingrid; Trovik, Jone; Vergote, Ignace et al. (2011). The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium a collaborative study. (ekstern lenke)
• Vandenput, Ingrid; Trovik, Jone; Leunen, Karin et al. (2011). Evolution in endometrial cancer evidence from an immunohistochemical study. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2011). Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer. (ekstern lenke)
• Bhriain, Hannah Ni; Trovik, Jone; Wik, Elisabeth et al. (2009). Plasma calprotectin concentrations in women with endometrial carcinoma. (ekstern lenke)
• Wik, Elisabeth; Trovik, Jone; Iversen, Ole-Erik et al. (2009). Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. (ekstern lenke)
• Salvesen, Helga Birgitte; Carter, Scott L.; Mannelqvist, Monica et al. (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (ekstern lenke)
• Dutt, Amit; Salvesen, Helga; Chent, Tzu-Hsiu et al. (2008). Drug-sensitive FGFR2 mutations in endometrial carcinoma. (ekstern lenke)
• Egeland, Philip; Gjøen, John Espen; Trovik, Jone et al. (2007). Gynekologiske fistler til urinveier og tarm. (ekstern lenke)

Errata

• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (ekstern lenke)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (ekstern lenke)
• Meinich, Tale Jeanette; Trovik, Jone (2020). Erratum: Early maternal weight gain as a risk factor for SGA in pregnancies with hyperemesis gravidarum: A 15-year hospital cohort study (BMC Pregnancy and Childbirth (2020) 20:255 DOI: 10.1186/s12884-020-02947-3). (ekstern lenke)

Lærebok

• Knudsen, Ulla Breth; Gemzell-Danielsson, Kristina; Trovik, Jone et al. (2020). Obstetrics and Gynecology. NFOG textbook for medical students. (ekstern lenke)

Vitenskapelig foredrag

• Holst, Lone; Heitmann, Kristine; Kristiansen, Cathrine Helgestad et al. (2019). European antiemetic regulations (restricting metoclopramide use) increases admission rates due to hyperemesis gravidarum.. (ekstern lenke)
• Ytre-Hauge, Sigmund; Hanson, E; Lundervold, Arvid et al. (2015). Preoperative tumor texture at MRI predicts deep myometrial invasion and non-endometrioid subtype in endometrial carcinomas. (ekstern lenke)

Poster

• Nilsen, Charlotte; Lunestad, Mona; Engelsen, Ingeborg Bøe et al. (2015). Nasogastric feeding in hyperemesis gravidarum; tube positioning by ward nurse, a pilot study. (ekstern lenke)
• Husby, Jenny Hild Aase; Reitan, Bernt; Trovik, Jone et al. (2014). Metabolic tumor volume on FDG-PET/CT predicts deep myometrial invasion, lymph node metastases and survival in patients with endometrial carcinoma. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (ekstern lenke)

Leserinnlegg

• Trovik, Jone; Vikanes, Åse Vigdis (2015). Kvantifisering av svangerskapskvalme :. (ekstern lenke)
• Trovik, Jone (2014). Ikke "bare" svangerskapskvalme. (ekstern lenke)
• Halle, Mari Kyllesø; Werner, Henrica Maria Johanna; Krakstad, Camilla et al. (2012). Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2010). Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. (ekstern lenke)

Intervju

• Sørbye, Sveinung Wergeland; Stålcrantz, Jeanette; Trovik, Jone et al. (2014). - Alle kvinner bør ta denne vaksinen. (ekstern lenke)

Doktorgradsavhandling

• Trovik, Jone (2012). Endometrial carcinoma; can biomarkers aid in the prediction of aggressive disease? A study with focus on preoperative tumour markers. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin